Enterprise Estonia supported the project "Development of a POC test for rapid diagnosis of pathogens (incl. COVID-19)". The project period is 01.02.2021-31.12.2023.
So far, Solis BioDyne has offered the gold standard solutions for diagnostics- RT-qPCR. Now, SARS-CoV-2 has highlighted the need for a wider variety of methods for COVID-19 analysis of patient samples.
As part of the European Regional Development Fund-supported project, Solis BioDyne is developing an innovative isothermal polymerase from which a number of reagents are being developed for use in various methods. Isothermal polymerases are increasingly used in close-up patient studies for the rapid analysis of various pathogens, allowing the analysis to be performed within 30 minutes without complex equipment.
The second goal of the project is the development of freeze-drying technology for Solis BioDyne products. Freeze-drying makes it possible to significantly extend the shelf life of products and to create new types of analytical methods. The total cost of the project is 1,368,200 €, of which the European Regional Development Fund covers up to 1,094,560€.
Summer has a way of changing the rhythm of a laboratory. Temperatures rise, team members take well-earned holidays, and deliveries do not always arrive exactly when expected. A shipment may take longer in transit than planned. A package might reach the laboratory on a particularly hot afternoon. With Solis BioDyne’s products, summer heat does not have to bring research to a standstill.
From 2010, Solis BioDyne had stepped into a whole new area of enzyme development. What began as an ambitious R&D project led to FIREScript®, SOLIScript®, RiboGrip® RNase Inhibitor, and the SolisFAST® product line. Find out more about the development process in this blog post.
In high-throughput environments such as diagnostic kit development, pharmaceutical research, and OEM manufacturing, reducing PCR and qPCR costs is rarely as simple as choosing the lowest-priced reagent. Cost per reaction is often the first metric considered, but it does not fully reflect the true financial impact of a workflow.
Modern agriculture increasingly relies on genetic information to accelerate crop improvement. Plant breeders routinely screen thousands of samples to identify genetic variants associated with desirable traits such as yield, disease resistance, drought tolerance, and quality characteristics.
